Antianaerobic activity of gatifloxacin

Drugs

Volumn 58, Issue SUPPL. 2, 1999, Pages 113-110

  Ednie, Lois M ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; CLINDAMYCIN; GATIFLOXACIN; METRONIDAZOLE; SPARFLOXACIN; SULTAMICILLIN; TROVAFLOXACIN;

ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; CONFERENCE PAPER; CONTROLLED STUDY; FUSOBACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PORPHYROMONAS ENDODONTALIS; PREVOTELLA;

BACTERIA (MICROORGANISMS); BACTEROIDES FRAGILIS; FUSOBACTERIUM; PORPHYROMONAS ENDODONTALIS; PREVOTELLA;

EID: 0032748410     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958002-00024     Document Type: Conference Paper

References (11)

1. Appelbaum PC, Spangler SK, Jacobs MR. Susceptibility of 539 gram-positive and -negative anaerobes to new agents, including RP 59500, biapenem, trospectomycin and piperacillin/tazobactam. J Antimicrob Chemother 1993; 32: 223-31
2. Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother 1997; 40: 639-51
3. Hosaka M, Kinoshita S, Toyama A, et al. Antibacterial properties of AM-1155, a new 8-methoxy quinolone. J Antimicrob Chemother 1995; 36: 293-301
4. Hosaka M, Yasue T, Fukuda H, et al. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother 1992; 36: 2108-17
5. Kato N, Kato H, Tanaka-Bandoh K, et al. Comparative in-vitro and in-vivo activity of AM-1155 against anaerobic bacteria. J Antimicrob Chemother 1997; 40: 631-7
6. Nakashima M, Uematsu T, Kosuge K, et al. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob Agents Chemother 1995; 39: 2635-40
7. Wakabayashi E, Mitsuhashi S. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother 1994; 38: 594-601
8. Wise R, Brenwald NP, Andrews JM, et al. 1997. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones. J Antimicrob Chemother 1997; 39: 447-52
9. Wexler HM, Molitoris E, Molitoris D, et al. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria. Antimicrob Agents Chemother 1996 40: 2232-5
10. Goldstein EJC, Citron DM. Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and Win 57273 against anaerobic bacteria. Antimicrob Agents Chemother 1992; 36: 1158-62
11. Spangler SK, Jacobs MR, Appelbaum PC. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes. Antimicrob Agents Chemother 1994; 38: 2471-6